Behind the Study: P4HA1 Protein and Colorectal Cancer
November 22, 2021
Dr. Michael Roehrl from Memorial Sloan Kettering Cancer Center describes the research paper he co-authored that was published by Oncotarget on February 25, 2020, entitled, “Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early… read more
